Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	972.23	214.23	19.98
Graham Fair Price	-16.81	21.74	26.13
PEG	-31.98	0.20	-0.29
Price/Book	-2.63	1.53	1.57
Price/Cash Flow	154.22	20.00	7.87
Prices/Earnings	40.55	-33.15	23.58
Price/Sales	8.67	3.93	3.62
Price/FCF	154.22	20.00	7.87
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-43.47	0.44	0.77
Operating Margin	-71.13	-0.03	0.10
ROA	-35.08	< 0.005	< 0.005
ROE	0.02	-0.01	-30.72
ROIC	0.01	< 0.005	-65.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.09	80.83
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.69	-1.26	-83.53
EPS QOQ	-0.82	-1.69	-106.63
FCF QOQ	2.77	-0.62	-77.73
Revenue QOQ	-0.23	-0.10	54.23
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2122.28	53.77	-97.47
Days Sales Outstanding (DSO)	82.54	75.56	-8.46
Inventory Turnover	0.04	1.67	3846.62
Debt/Capitalization	0.62	0.62	-0.67
Quick Ratio	0.36	0.30	-16.04
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	42.65	42.63	-0.05
Cash	-0.01	0.70	5296.39
Capex	-0.36	-0.46	-26.55
Free Cash Flow	8.53	3.27	-61.72
Revenue	18.56	16.62	-10.45
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.45	2.56	4.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.21	109.51	972.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating